Chaoju Eye Care Holdings Ltd. (HK:2219) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Chaoju Eye Care Holdings Ltd., through its subsidiary Chaoju Medical Technology, has subscribed to new structured deposit products with the Bank of China, totaling RMB150 million. These deposits, guaranteed in principal with low risk and an expected annualized return of 1.5% to 2.9%, are linked to the EUR/USD exchange rate. The investment, funded by the group’s surplus cash, is classified as a discloseable transaction under the Listing Rules, meaning it requires reporting and announcement but not shareholder approval.
For further insights into HK:2219 stock, check out TipRanks’ Stock Analysis page.